Reduction in Akt phosphorylation, increase in glycogen synthase kinase 3β (GSK3) and c-Jun NH2-terminal kinase (JNK) activities in muscle and islets that may account for rapamycin-induced insulin resistance and cell apoptosis. The gene discussed is AKT1; the disease is Insulin resistance.